Status:

COMPLETED

SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism

Lead Sponsor:

Sanofi

Conditions:

Pulmonary Embolism

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Patients who have a pulmonary embolism (blood clot in the lung) will be treated in this study. The purpose of the study is to compare the safety and effectiveness of a new injectable anticoagulant (bl...

Eligibility Criteria

Inclusion

  • Confirmed acute symptomatic Pulmonary Embolism (PE) with or without concomitant Deep Vein Thrombosis (DVT)
  • Written informed consent

Exclusion

  • Legal lower age limitations (country specific)
  • Thrombectomy, insertion of a caval filter, or use of a fibrinolytic agent to treat the current episode of PE
  • Other indication for VKA than PE/DVT
  • More than 36 hours pre-randomization treatment with therapeutic dosages of (LMW)heparin or initiation of VKA treatment prior to randomization
  • Participation in another pharmacotherapeutic study within the prior 30 days
  • Creatinine clearance \<10 mL/min, severe hepatic disease, or bacterial endocarditis
  • Life expectancy \<3 months
  • Active bleeding or high risk for bleeding
  • Uncontrolled hypertension: systolic blood pressure \>180 mm Hg or diastolic blood pressure \>110 mm Hg
  • Pregnancy or childbearing potential without proper contraceptive measures or women who are breastfeeding
  • Any other contraindication listed in the labeling of warfarin, acenocoumarol, unfractionated heparin, enoxaparin, or tinzaparin

Key Trial Info

Start Date :

June 1 2003

Trial Type :

INTERVENTIONAL

End Date :

October 1 2005

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00062803

Start Date

June 1 2003

End Date

October 1 2005

Last Update

April 29 2009

Active Locations (93)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 24 (93 locations)

1

Jerry L. Pettic VA Medical Center

Loma Linda, California, United States

2

University of California, San Diego Medical Center

San Diego, California, United States

3

Anschutz Cancer Pavilion

Aurora, Colorado, United States

4

University of Colorado Hospital

Denver, Colorado, United States